180 related articles for article (PubMed ID: 11739761)
1. Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis.
Payton M; Gifford C; Schartau P; Hagemeier C; Mushtaq A; Lucas S; Pinter K; Sim E
Microbiology (Reading); 2001 Dec; 147(Pt 12):3295-302. PubMed ID: 11739761
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance.
Payton M; Auty R; Delgoda R; Everett M; Sim E
J Bacteriol; 1999 Feb; 181(4):1343-7. PubMed ID: 9973365
[TBL] [Abstract][Full Text] [Related]
3. Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
Kawamura A; Sandy J; Upton A; Noble M; Sim E
Protein Expr Purif; 2003 Jan; 27(1):75-84. PubMed ID: 12509987
[TBL] [Abstract][Full Text] [Related]
4. Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism.
Upton AM; Mushtaq A; Victor TC; Sampson SL; Sandy J; Smith DM; van Helden PV; Sim E
Mol Microbiol; 2001 Oct; 42(2):309-17. PubMed ID: 11703656
[TBL] [Abstract][Full Text] [Related]
5. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
Sandy J; Mushtaq A; Kawamura A; Sinclair J; Sim E; Noble M
J Mol Biol; 2002 May; 318(4):1071-83. PubMed ID: 12054803
[TBL] [Abstract][Full Text] [Related]
6. Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis.
Sandy J; Holton S; Fullam E; Sim E; Noble M
Protein Sci; 2005 Mar; 14(3):775-82. PubMed ID: 15722451
[TBL] [Abstract][Full Text] [Related]
7. Mutational and expression analysis of tbnat and its response to isoniazid.
Sholto-Douglas-Vernon C; Sandy J; Victor TC; Sim E; Helden PD
J Med Microbiol; 2005 Dec; 54(Pt 12):1189-1197. PubMed ID: 16278433
[TBL] [Abstract][Full Text] [Related]
8. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
[TBL] [Abstract][Full Text] [Related]
9. Arylamine N-acetyltransferases in mycobacteria.
Sim E; Sandy J; Evangelopoulos D; Fullam E; Bhakta S; Westwood I; Krylova A; Lack N; Noble M
Curr Drug Metab; 2008 Jul; 9(6):510-9. PubMed ID: 18680471
[TBL] [Abstract][Full Text] [Related]
10. High throughput screening of 7-methylpicene-1,2-diol as arylamine N-acetyltransferase (NAT) inhibitor to establish a isoniazid supplement in anti-tubercular therapy.
Chowdhury A; Paul P; Choudhury MD
Comb Chem High Throughput Screen; 2013 Nov; 16(9):721-5. PubMed ID: 23701008
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an oxidoreductase from the arylamine N-acetyltransferase operon in Mycobacterium smegmatis.
Evangelopoulos D; Cronin N; Daviter T; Sim E; Keep NH; Bhakta S
FEBS J; 2011 Dec; 278(24):4824-32. PubMed ID: 21972977
[TBL] [Abstract][Full Text] [Related]
12. Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase.
Westwood IM; Holton SJ; Rodrigues-Lima F; Dupret JM; Bhakta S; Noble ME; Sim E
Biochem J; 2005 Jan; 385(Pt 2):605-12. PubMed ID: 15447630
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
[TBL] [Abstract][Full Text] [Related]
14. Expression and purification of the rifamycin amide synthase, RifF, an enzyme homologous to the prokaryotic arylamine N-acetyltransferases.
Pompeo F; Mushtaq A; Sim E
Protein Expr Purif; 2002 Feb; 24(1):138-51. PubMed ID: 11812235
[TBL] [Abstract][Full Text] [Related]
15. Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.
Westwood IM; Bhakta S; Russell AJ; Fullam E; Anderton MC; Kawamura A; Mulvaney AW; Vickers RJ; Bhowruth V; Besra GS; Lalvani A; Davies SG; Sim E
Protein Cell; 2010 Jan; 1(1):82-95. PubMed ID: 21204000
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis.
Dhandayuthapani S; Zhang Y; Mudd MH; Deretic V
J Bacteriol; 1996 Jun; 178(12):3641-9. PubMed ID: 8655566
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of a putative AraC transcriptional regulator from Mycobacterium smegmatis.
Evangelopoulos D; Gupta A; Lack NA; Maitra A; ten Bokum AM; Kendall S; Sim E; Bhakta S
Tuberculosis (Edinb); 2014 Dec; 94(6):664-71. PubMed ID: 25443504
[TBL] [Abstract][Full Text] [Related]
18. Arylamine N-acetyltransferases - of mice, men and microorganisms.
Upton A; Johnson N; Sandy J; Sim E
Trends Pharmacol Sci; 2001 Mar; 22(3):140-6. PubMed ID: 11239577
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation.
Wang XD; Gu J; Wang T; Bi LJ; Zhang ZP; Cui ZQ; Wei HP; Deng JY; Zhang XE
Mol Microbiol; 2011 Dec; 82(6):1375-91. PubMed ID: 22026918
[TBL] [Abstract][Full Text] [Related]
20. Export of recombinant Mycobacterium tuberculosis superoxide dismutase is dependent upon both information in the protein and mycobacterial export machinery. A model for studying export of leaderless proteins by pathogenic mycobacteria.
Harth G; Horwitz MA
J Biol Chem; 1999 Feb; 274(7):4281-92. PubMed ID: 9933629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
